Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis

Archives of Internal Medicine
Shih-Te TuMing-Chia Hsieh

Abstract

No study to date has evaluated whether multifactorial intervention can prevent diabetic nephropathy in patients with type 2 diabetes mellitus and normoalbuminuria. We evaluated the effect of tightly controlling multiple factors recommended by the American Diabetes Association (ADA) on the development and prevention of diabetic nephropathy in Chinese patients with type 2 diabetes mellitus and normoalbuminuria during a 4(1/2)-year period. A longitudinal cohort study enrolled 1290 patients with type 2 diabetes and normoalbuminuria who received intensified treatment to meet the following ADA recommended goals: hemoglobin A(1c )(HbA(1c)), less than 7%; systolic blood pressure, less than 130 mm Hg; diastolic blood pressure, less than 80 mm Hg; low-density lipoprotein cholesterol, less than 100 mg/dL; triglycerides, less than 150 mg/dL; and high-density lipoprotein cholesterol, greater than 40 mg/dL for men and greater than 50 mg/dL for women. During the study period, 211 patients (16.4%) developed new-onset microalbuminuria. A significant association was found between the achievement of ADA goals, including HbA(1c) level less than 7% (hazard ratio [HR], 0.729; 95% confidence interval [CI], 0.553-0.906; P = .03), systolic blood pressu...Continue Reading

Citations

Sep 13, 2013·American Journal of Hypertension·Kentaro NakaiShinichi Nishi
Jun 10, 2011·Current Cardiovascular Risk Reports·Juliana C N ChanXilin Yang
May 15, 2013·Current Cardiovascular Risk Reports·Ankur JindalJames R Sowers
Jan 11, 2012·Der Internist·C ChatzikyrkouJ Menne
Jul 26, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ko HanaiYasuhiko Iwamoto
Jan 2, 2013·Journal of Diabetes and Its Complications·I Te LeeWayne H H Sheu
Jun 2, 2016·Journal of Diabetes Research·Shamala AyaduraiSiti Norlina Md Said
Jul 12, 2011·Diabetes Research and Clinical Practice·Juliana C N ChanPhilip Barter
Mar 23, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Nabil MtiraouiWassim Y Almawi
May 31, 2018·Postgraduate Medicine·Angelika BazylukEdyta Zbroch
Jul 17, 2010·Journal of Hypertension·Jan MenneHermann Haller
Dec 31, 2014·Journal of the Chinese Medical Association : JCMA·Chern-En ChiangShing-Jong Lin
Jan 11, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Makoto KuranoYutaka Yatomi
Feb 9, 2011·European Journal of Clinical Investigation·Ming-Chia HsiehShih-Te Tu
Mar 26, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·C WyshamK Taylor
Apr 25, 2020·Journal of Nephrology·Giuseppina RussoSalvatore De Cosmo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.